Baseline levels of miR-223-3p correlate with the effectiveness of electroconvulsive therapy in patients with major depression

[1]  C. Zheng,et al.  Prelimbic cortex miR-34a contributes to (2R,6R)-hydroxynorketamine-mediated antidepressant-relevant actions , 2022, Neuropharmacology.

[2]  E. Seifritz,et al.  Differential expression of serum extracellular vesicle microRNAs and analysis of target-gene pathways in major depressive disorder , 2022, Biomarkers in Neuropsychiatry.

[3]  Shun Yuan,et al.  miR-223: An Immune Regulator in Infectious Disorders , 2021, Frontiers in Immunology.

[4]  A. Leaver,et al.  Parsing the Network Mechanisms of Electroconvulsive Therapy , 2021, Biological Psychiatry.

[5]  T. Schulze,et al.  A microRNA signature that correlates with cognition and is a target against cognitive decline , 2021, EMBO molecular medicine.

[6]  P. Falkai,et al.  Exercise as a model to identify microRNAs linked to human cognition: a role for microRNA-409 and microRNA-501 , 2021, Translational Psychiatry.

[7]  A. Attia,et al.  Crosstalk Among NLRP3 Inflammasome, ETBR Signaling, and miRNAs in Stress-Induced Depression-Like Behavior: a Modulatory Role for SGLT2 Inhibitors , 2021, Neurotherapeutics.

[8]  P. Jiao,et al.  miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation , 2021, International journal of biological sciences.

[9]  A. M. Dale,et al.  The Neurobiological Effects of Electroconvulsive Therapy Studied Through Magnetic Resonance: What Have We Learned, and Where Do We Go? , 2021, Biological Psychiatry.

[10]  M. Lindow,et al.  A large-scale genome-wide gene expression analysis in peripheral blood identifies very few differentially expressed genes related to antidepressant treatment and response in patients with major depressive disorder , 2021, Neuropsychopharmacology.

[11]  Yingying Zhu,et al.  Emerging role of microRNAs in major depressive disorder and its implication on diagnosis and therapeutic response. , 2021, Journal of affective disorders.

[12]  N. Jaafari,et al.  On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos? , 2021, Journal of neuroinflammation.

[13]  C. Martelli,et al.  Cytokines changes associated with electroconvulsive therapy in patients with treatment-resistant depression: a Meta-analysis , 2021, Psychiatry Research.

[14]  P. Vajkoczy,et al.  The Effects of Deep Brain Stimulation of the Subthalamic Nucleus on Vascular Endothelial Growth Factor, Brain-Derived Neurotrophic Factor, and Glial Cell Line-Derived Neurotrophic Factor in a Rat Model of Parkinson’s Disease , 2020, Stereotactic and Functional Neurosurgery.

[15]  C. Nemeroff,et al.  The Bidirectional Relationship of Depression and Inflammation: Double Trouble , 2020, Neuron.

[16]  K. Narr,et al.  Inflammation and depression treatment response to electroconvulsive therapy: Sex-specific role of interleukin-8 , 2020, Brain, Behavior, and Immunity.

[17]  R. Rosenheck,et al.  Effectiveness of electroconvulsive therapy in patients with “less treatment‐resistant” depression by the Maudsley Staging Model , 2020, Brain and behavior.

[18]  Shugui Gao,et al.  Inflammatory cytokines derived from peripheral blood contribute to the modified electroconvulsive therapy-induced cognitive deficits in major depressive disorder , 2020, European Archives of Psychiatry and Clinical Neuroscience.

[19]  Yogesh K. Dwivedi,et al.  Exploiting Circulating MicroRNAs as Biomarkers in Psychiatric Disorders , 2020, Molecular Diagnosis & Therapy.

[20]  M. Mattson,et al.  Astrocyte- and Neuron-Derived Extracellular Vesicles from Alzheimer’s Disease Patients Effect Complement-Mediated Neurotoxicity , 2020, bioRxiv.

[21]  Lan Zheng,et al.  Aerobic Exercise Inhibits CUMS-Depressed Mice Hippocampal Inflammatory Response via Activating Hippocampal miR-223/TLR4/MyD88-NF-κB Pathway , 2020, International journal of environmental research and public health.

[22]  G. Salum,et al.  Precision non-implantable neuromodulation therapies: a perspective for the depressed brain , 2020, Revista brasileira de psiquiatria.

[23]  P. Parizel,et al.  Inflammation, Hippocampal Volume, and Therapeutic Outcome following Electroconvulsive Therapy in Depressive Patients: A Pilot Study , 2020, Neuropsychobiology.

[24]  K. Conant,et al.  Extracellular matrix remodeling with stress and depression: Studies in human, rodent and zebrafish models , 2020, The European journal of neuroscience.

[25]  Shijie Jin,et al.  Exosome reporter mice reveal the involvement of exosomes in mediating neuron to astroglia communication in the CNS , 2019, Nature Communications.

[26]  D. Richter,et al.  Attenuated palmitoylation of serotonin receptor 5-HT1A affects receptor function and contributes to depression-like behaviors , 2019, Nature Communications.

[27]  P. Bekinschtein,et al.  Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain , 2019, Front. Cell. Neurosci..

[28]  F. Giuliani,et al.  The Role of Inflammation in Depression and Fatigue , 2019, Front. Immunol..

[29]  J. Ting,et al.  The NLRP3 inflammasome: molecular activation and regulation to therapeutics , 2019, Nature Reviews Immunology.

[30]  K. Brymer,et al.  Exploring the Potential Antidepressant Mechanisms of TNFα Antagonists , 2019, Front. Neurosci..

[31]  Yogesh K. Dwivedi.  MicroRNAs in depression and suicide: Recent insights and future perspectives. , 2018, Journal of affective disorders.

[32]  G. Meister,et al.  Regulation of microRNA biogenesis and its crosstalk with other cellular pathways , 2018, Nature Reviews Molecular Cell Biology.

[33]  P. Péran,et al.  Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review , 2018, Brain Stimulation.

[34]  B. Sabbe,et al.  Prediction of electroconvulsive therapy response and remission in major depression: meta-analysis , 2018, The British Journal of Psychiatry.

[35]  R. Wolff,et al.  MicroRNA‐transcription factor interactions and their combined effect on target gene expression in colon cancer cases , 2017, Genes, chromosomes & cancer.

[36]  H. Cameron,et al.  Stress and Loss of Adult Neurogenesis Differentially Reduce Hippocampal Volume , 2017, Biological Psychiatry.

[37]  G. Calin,et al.  Cell‐to‐cell communication: microRNAs as hormones , 2017, Molecular oncology.

[38]  G. Blackshields,et al.  Peripheral blood microRNA and VEGFA mRNA changes following electroconvulsive therapy: implications for psychotic depression , 2017, Acta psychiatrica Scandinavica.

[39]  T. Standiford,et al.  Neutrophil transfer of miR-223 to lung epithelial cells dampens acute lung injury in mice , 2017, Science Translational Medicine.

[40]  M. Kaster,et al.  NLRP3 inflammasome-driven pathways in depression: Clinical and preclinical findings , 2017, Brain, Behavior, and Immunity.

[41]  E. Goetzl,et al.  Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes , 2017, Front. Neurosci..

[42]  Ji-wen Bu,et al.  Neurons secrete miR-132-containing exosomes to regulate brain vascular integrity , 2017, Cell Research.

[43]  J. Pujol,et al.  Brain volumetric and metabolic correlates of electroconvulsive therapy for treatment-resistant depression: a longitudinal neuroimaging study , 2017, Translational Psychiatry.

[44]  O. Kampman,et al.  Changes in interleukin‐6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression , 2017, Acta psychiatrica Scandinavica.

[45]  D. Mohr,et al.  Major depressive disorder , 2016, Nature Reviews Disease Primers.

[46]  T. Dinan,et al.  MicroRNAs as biomarkers for major depression: a role for let-7b and let-7c , 2016, Translational psychiatry.

[47]  L. Sandvik,et al.  Recovery from major depressive disorder episode after non‐pharmacological treatment is associated with normalized cytokine levels , 2016, Acta psychiatrica Scandinavica.

[48]  Shantanu H. Joshi,et al.  Electroconvulsive therapy and structural neuroplasticity in neocortical, limbic and paralimbic cortex , 2016, Translational psychiatry.

[49]  K. Jansen,et al.  The effect of proinflammatory cytokines in Cognitive Behavioral Therapy , 2015, Journal of Neuroimmunology.

[50]  Knut Engedal,et al.  The course of depression in late life as measured by the Montgomery and Asberg Depression Rating Scale in an observational study of hospitalized patients , 2015, BMC Psychiatry.

[51]  A. Jose.  Movement of regulatory RNA between animal cells , 2015, Genesis.

[52]  M. Halushka,et al.  Extracellular vesicle microRNA transfer in cardiovascular disease. , 2015, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[53]  Laura Inés Furlong,et al.  PsyGeNET: a knowledge platform on psychiatric disorders and their genes , 2015, Bioinform..

[54]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[55]  Chih-Hsin Tang,et al.  Brain-derived neurotrophic factor increases vascular endothelial growth factor expression and enhances angiogenesis in human chondrosarcoma cells. , 2014, Biochemical pharmacology.

[56]  S. Dudoit,et al.  Normalization of RNA-seq data using factor analysis of control genes or samples , 2014, Nature Biotechnology.

[57]  M. Cordero,et al.  NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder , 2014, Brain, Behavior, and Immunity.

[58]  J. Prudic,et al.  Current electroconvulsive therapy practice and research in the geriatric population. , 2014, Neuropsychiatry.

[59]  Andreas Meyer-Lindenberg,et al.  Electroconvulsive Therapy Induces Neurogenesis in Frontal Rat Brain Areas , 2013, PloS one.

[60]  R. Duman,et al.  The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses , 2013, Brain, Behavior, and Immunity.

[61]  Anna K Rieger,et al.  NLRP3 Inflammasome Activity Is Negatively Controlled by miR-223 , 2012, The Journal of Immunology.

[62]  T. Dinan,et al.  Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depression , 2012, Molecular Psychiatry.

[63]  Kerang Zhang,et al.  A polymorphism in the microRNA-30e precursor associated with major depressive disorder risk and P300 waveform. , 2010, Journal of affective disorders.

[64]  L. Price,et al.  Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era , 2010, Expert opinion on pharmacotherapy.

[65]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[66]  S. Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[67]  Ahmad R. Hariri,et al.  Interleukin-6 Covaries Inversely with Hippocampal Grey Matter Volume in Middle-Aged Adults , 2008, Biological Psychiatry.

[68]  K. Hestad,et al.  Raised Plasma Levels of Tumor Necrosis Factor &agr; in Patients With Depression: Normalization During Electroconvulsive Therapy , 2003, The journal of ECT.

[69]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[70]  D. F. Drake,et al.  A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. , 2013, JAMA psychiatry.

[71]  P. Zamore,et al.  MicroRNA therapeutics , 2011, Gene Therapy.